InsiderTrades.com logo
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel

ALDX Insider Trading

Insider Ownership Percentage: 7.00%
Insider Buying (Last 12 Months): $2,803,640.29
Insider Selling (Last 12 Months): $0.00

Aldeyra Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Aldeyra Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aldeyra Therapeutics Share Price & Price History

Current Price: $8.06
Price Change: ▲ Price Increase of +0.63 (8.48%)
As of 03/22/2023 01:00 AM ET

This chart shows the closing price history over time for ALDX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel

Aldeyra Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/10/2022Perceptive Advisors LlcMajor ShareholderBuy15,000$7.85$117,750.0011,350,085View SEC Filing Icon  
8/8/2022Perceptive Advisors LlcMajor ShareholderBuy97,000$7.24$702,280.0011,235,085View SEC Filing Icon  
8/3/2022Perceptive Advisors LlcMajor ShareholderBuy100,000$5.84$584,000.0010,901,985View SEC Filing Icon  
8/1/2022Perceptive Advisors LlcMajor ShareholderBuy144,185$5.05$728,134.2510,389,579View SEC Filing Icon  
7/28/2022Perceptive Advisors LlcMajor ShareholderBuy119,392$5.00$596,960.0010,023,271View SEC Filing Icon  
6/23/2022Martin Joseph JoyceDirectorBuy4,323$3.48$15,044.0423,967View SEC Filing Icon  
6/23/2022Todd C BradyCEOBuy17,700$3.36$59,472.001,216,535View SEC Filing Icon  
5/3/2021Perceptive Advisors LlcMajor ShareholderBuy1,200,000$12.50$15,000,000.00View SEC Filing Icon  
1/19/2021Perceptive Advisors LlcMajor ShareholderBuy1,368,421$9.50$12,999,999.50View SEC Filing Icon  
1/7/2021Perceptive Advisors LlcMajor ShareholderBuy500,000$8.13$4,065,000.00View SEC Filing Icon  
7/9/2020Perceptive Advisors LlcMajor ShareholderBuy3,200,000$4.25$13,600,000.00View SEC Filing Icon  
See Full Table
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel

SEC Filings (Institutional Ownership Changes) for Aldeyra Therapeutics (NASDAQ:ALDX)

63.11% of Aldeyra Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ALDX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Aldeyra Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/24/2023Natixis44,258$0.31M0.0%N/A0.076%Search for SEC Filing on Google Icon
2/15/2023Jane Street Group LLC63,182$0.44M0.0%N/A0.108%Search for SEC Filing on Google Icon
2/15/2023Tang Capital Management LLC272,293$1.90M0.3%-61.1%0.465%Search for SEC Filing on Google Icon
2/15/2023Laidlaw Wealth Management LLC18,000$0.13M0.0%N/A0.031%Search for SEC Filing on Google Icon
2/15/2023Millennium Management LLC850,088$5.92M0.0%+31.5%1.452%Search for SEC Filing on Google Icon
2/15/2023Morgan Stanley315,250$2.19M0.0%+4.2%0.538%Search for SEC Filing on Google Icon
2/15/2023Man Group plc19,967$0.14M0.0%N/A0.034%Search for SEC Filing on Google Icon
2/15/2023Eagle Asset Management Inc.1,771,689$12.33M0.1%+21.5%3.025%Search for SEC Filing on Google Icon
2/15/2023EAM Investors LLC198,228$1.38M0.3%-15.2%0.339%Search for SEC Filing on Google Icon
2/15/2023Alps Advisors Inc.39,756$0.28M0.0%+25.0%0.068%Search for SEC Filing on Google Icon
2/15/2023Boothbay Fund Management LLC13,525$94K0.0%N/A0.023%Search for SEC Filing on Google Icon
2/14/2023Price T Rowe Associates Inc. MD49,587$0.35M0.0%+44.2%0.085%Search for SEC Filing on Google Icon
2/14/2023Cetera Advisor Networks LLC14,408$100K0.0%-32.8%0.025%Search for SEC Filing on Google Icon
2/14/2023Verition Fund Management LLC1,558,322$10.85M0.2%-35.1%2.661%Search for SEC Filing on Google Icon
2/14/2023683 Capital Management LLC29,519$0.21M0.0%-95.8%0.050%Search for SEC Filing on Google Icon
2/14/2023Marshall Wace LLP322,581$2.25M0.0%+61.2%0.551%Search for SEC Filing on Google Icon
2/14/2023Two Sigma Investments LP450,687$3.14M0.0%-22.5%0.770%Search for SEC Filing on Google Icon
2/14/2023Dorsey Wright & Associates3,580$25K0.0%N/A0.006%Search for SEC Filing on Google Icon
2/13/2023Natixis44,258$0.30M0.0%N/A0.076%Search for SEC Filing on Google Icon
2/13/2023Wells Fargo & Company MN317,847$2.21M0.0%+2.4%0.543%Search for SEC Filing on Google Icon
2/13/2023Barclays PLC29,779$0.21M0.0%+233.3%0.051%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC213,500$1.49M0.0%-43.6%0.365%Search for SEC Filing on Google Icon
2/13/2023Joseph P. Lucia & Associates LLC12,000$62K0.0%N/A0.020%Search for SEC Filing on Google Icon
2/13/2023Geode Capital Management LLC466,577$3.25M0.0%-0.6%0.797%Search for SEC Filing on Google Icon
2/13/2023American Century Companies Inc.13,169$92K0.0%N/A0.022%Search for SEC Filing on Google Icon
2/13/2023GSA Capital Partners LLP143,208$1M0.1%+37.9%0.245%Search for SEC Filing on Google Icon
2/10/2023Bank of America Corp DE87,491$0.61M0.0%-17.9%0.149%Search for SEC Filing on Google Icon
2/10/2023Connor Clark & Lunn Investment Management Ltd.184,894$1.29M0.0%-18.3%0.316%Search for SEC Filing on Google Icon
2/10/2023Victory Capital Management Inc.174,290$1.21M0.0%+158.6%0.298%Search for SEC Filing on Google Icon
2/10/2023HRT Financial LP79,092$0.55M0.0%N/A0.135%Search for SEC Filing on Google Icon
2/9/2023Victory Capital Management Inc.174,290$1.21M0.0%+158.6%0.298%Search for SEC Filing on Google Icon
2/9/2023Dimensional Fund Advisors LP890,232$6.20M0.0%+30.9%1.520%Search for SEC Filing on Google Icon
2/9/2023Citigroup Inc.44,820$0.31M0.0%+794.3%0.077%Search for SEC Filing on Google Icon
2/8/2023Thrivent Financial for Lutherans116,131$0.81M0.0%+536.6%0.198%Search for SEC Filing on Google Icon
2/7/2023Fox Run Management L.L.C.12,682$88K0.0%N/A0.022%Search for SEC Filing on Google Icon
2/2/2023Magnus Financial Group LLC10,370$72K0.0%N/A0.018%Search for SEC Filing on Google Icon
1/30/2023International Assets Investment Management LLC62,807$0.44M0.0%+6.0%0.107%Search for SEC Filing on Google Icon
1/26/2023Dupont Capital Management Corp230,491$1.60M0.1%-12.7%0.394%Search for SEC Filing on Google Icon
1/10/2023Woodstock Corp137,179$0.96M0.1%+6.2%0.234%Search for SEC Filing on Google Icon
12/8/2022Bank of New York Mellon Corp66,222$0.35M0.0%-15.6%0.113%Search for SEC Filing on Google Icon
11/15/2022Jacobs Levy Equity Management Inc.281,836$1.51M0.0%+20.1%0.481%Search for SEC Filing on Google Icon
11/15/2022Tang Capital Management LLC700,000$3.74M0.5%N/A1.195%Search for SEC Filing on Google Icon
11/15/2022Thrivent Financial for Lutherans18,241$97K0.0%-55.6%0.031%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Advisers LP897,600$4.79M0.0%+1.2%1.533%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Investments LP581,439$3.11M0.0%-4.1%0.993%Search for SEC Filing on Google Icon
11/15/2022Trexquant Investment LP19,675$0.11M0.0%N/A0.034%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.2,515,884$13.43M0.0%+3.2%4.296%Search for SEC Filing on Google Icon
11/15/2022Perceptive Advisors LLC11,350,085$60.61M1.8%+14.6%19.382%Search for SEC Filing on Google Icon
11/15/2022Price T Rowe Associates Inc. MD34,387$0.18M0.0%-24.1%0.059%Search for SEC Filing on Google Icon
11/15/2022Prosight Management LP1,210,800$6.47M3.5%-39.0%2.068%Search for SEC Filing on Google Icon
11/15/2022Knoll Capital Management LLC1,877,305$10.03M5.9%+24.9%3.206%Search for SEC Filing on Google Icon
11/15/2022Laurion Capital Management LP956,900$5.11M0.0%-1.5%1.634%Search for SEC Filing on Google Icon
11/15/2022Marshall Wace LLP200,163$1.07M0.0%+157.7%0.342%Search for SEC Filing on Google Icon
11/15/2022Bank of New York Mellon Corp66,222$0.35M0.0%-15.6%0.113%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.970,086$5.18M0.0%-0.5%1.657%Search for SEC Filing on Google Icon
11/14/2022683 Capital Management LLC700,000$3.74M0.3%-30.0%1.200%Search for SEC Filing on Google Icon
11/14/2022Cubist Systematic Strategies LLC116,285$0.62M0.0%+26.0%0.199%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC378,300$2.02M0.0%-26.4%0.649%Search for SEC Filing on Google Icon
11/14/2022Verition Fund Management LLC2,402,239$12.83M0.1%+26.4%4.119%Search for SEC Filing on Google Icon
11/10/2022Connor Clark & Lunn Investment Management Ltd.226,197$1.21M0.0%+233.1%0.388%Search for SEC Filing on Google Icon
11/10/2022ExodusPoint Capital Management LP33,685$0.18M0.0%+49.7%0.058%Search for SEC Filing on Google Icon
11/10/2022Dimensional Fund Advisors LP680,013$3.63M0.0%+720.1%1.166%Search for SEC Filing on Google Icon
11/10/2022Tower Research Capital LLC TRC 6,754$36K0.0%N/A0.012%Search for SEC Filing on Google Icon
11/10/2022UBS Group AG25,803$0.14M0.0%-96.6%0.044%Search for SEC Filing on Google Icon
11/8/2022Curi Wealth Management LLC21,500$0.12M0.0%N/A0.037%Search for SEC Filing on Google Icon
11/8/2022Eagle Asset Management Inc.1,458,008$7.79M0.1%-3.2%2.500%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC18,573$99K0.0%N/A0.032%Search for SEC Filing on Google Icon
11/7/2022Jump Financial LLC50,000$0.27M0.0%N/A0.086%Search for SEC Filing on Google Icon
11/3/2022Barclays PLC8,935$48K0.0%N/A0.015%Search for SEC Filing on Google Icon
11/2/2022Victory Capital Management Inc.67,390$0.36M0.0%N/A0.116%Search for SEC Filing on Google Icon
10/31/2022Dupont Capital Management Corp263,924$1.41M0.1%+67.0%0.453%Search for SEC Filing on Google Icon
10/25/2022Raymond James & Associates27,049$0.14M0.0%-13.4%0.046%Search for SEC Filing on Google Icon
10/11/2022Woodstock Corp129,179$0.69M0.1%+23.3%0.221%Search for SEC Filing on Google Icon
8/30/2022Verition Fund Management LLC1,901,191$7.59M0.1%-9.7%3.260%Search for SEC Filing on Google Icon
8/22/2022ExodusPoint Capital Management LP22,495$90K0.0%+11.7%0.039%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.1,184,584$4.73M0.0%-14.8%2.031%Search for SEC Filing on Google Icon
8/17/2022International Assets Investment Management LLC59,875$0.24M0.0%+4.8%0.103%Search for SEC Filing on Google Icon
8/16/2022Thrivent Financial for Lutherans41,113$0.16M0.0%N/A0.070%Search for SEC Filing on Google Icon
8/15/2022AQR Capital Management LLC40,954$0.16M0.0%N/A0.070%Search for SEC Filing on Google Icon
8/15/2022State Street Corp173,881$0.69M0.0%-80.2%0.298%Search for SEC Filing on Google Icon
8/15/2022Cubist Systematic Strategies LLC92,297$0.37M0.0%+560.0%0.158%Search for SEC Filing on Google Icon
8/15/2022Laurion Capital Management LP971,781$3.88M0.1%N/A1.666%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC1,236,752$4.94M0.0%+145.2%2.121%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC514,100$2.05M0.0%N/A0.881%Search for SEC Filing on Google Icon
8/13/2022Prosight Management LP1,985,883$7.92M6.2%+41.8%3.405%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp90,152$0.36M0.0%-79.5%0.155%Search for SEC Filing on Google Icon
8/12/2022FMR LLC674,584$2.69M0.0%+17,051.9%1.157%Search for SEC Filing on Google Icon
8/11/2022Deutsche Bank AG229,454$0.92M0.0%-22.4%0.393%Search for SEC Filing on Google Icon
8/11/2022UBS Group AG760,497$3.04M0.0%-20.8%1.304%Search for SEC Filing on Google Icon
8/11/2022Bank of Montreal Can80,700$0.32M0.0%N/A0.138%Search for SEC Filing on Google Icon
8/11/2022Alps Advisors Inc.34,581$0.14M0.0%-42.1%0.059%Search for SEC Filing on Google Icon
8/10/2022Eagle Asset Management Inc.1,505,938$6.01M0.0%+2.2%2.583%Search for SEC Filing on Google Icon
8/5/2022Connor Clark & Lunn Investment Management Ltd.67,914$0.27M0.0%N/A0.116%Search for SEC Filing on Google Icon
7/27/2022Assenagon Asset Management S.A.646,817$2.58M0.0%-33.7%1.109%Search for SEC Filing on Google Icon
7/13/2022Private Advisor Group LLC49,165$0.20M0.0%N/A0.084%Search for SEC Filing on Google Icon
7/11/2022Woodstock Corp104,734$0.42M0.1%+47.5%0.180%Search for SEC Filing on Google Icon
6/30/2022Amalgamated Bank7,928$35K0.0%N/A0.014%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE91,293$0.41M0.0%-72.7%0.157%Search for SEC Filing on Google Icon
6/2/2022Verition Fund Management LLC2,105,907$9.36M0.1%+54.1%3.612%Search for SEC Filing on Google Icon
5/27/2022Walleye Capital LLC41,652$0.19M0.0%-88.3%0.071%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Aldeyra Therapeutics logo
Aldeyra Therapeutics is a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseases. Two of the company’s lead compounds, reproxalap and ADX-629, target reactive aldehyde species (RASP), which are elevated in ocular and systemic inflammatory disease, leading to elevated levels of cytokine release via activation of a broad array of inflammatory factors, including NF-κB, inflammasomes, and Scavenger Receptor A. Reproxalap is being evaluated in Phase 3 clinical trials in patients with dry eye disease and allergic conjunctivitis. The company’s clinical pipeline also includes ADX-2191, a dihydrofolate reductase inhibitor in Phase 3 testing for proliferative vitreoretinopathy, and ADX-1612, a chaperome inhibitor in Phase 2 testing for COVID-19 and ovarian cancer.
Read More on Aldeyra Therapeutics

Today's Range

Now: $8.06
Low: $7.42
High: $8.22

50 Day Range

MA: $6.79
Low: $5.77
High: $8.06

52 Week Range

Now: $8.06
Low: $2.36
High: $8.22

Volume

1,164,235 shs

Average Volume

437,581 shs

Market Capitalization

$472.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.07

Who are the company insiders with the largest holdings of Aldeyra Therapeutics?

Aldeyra Therapeutics' top insider investors include:
  1. Perceptive Advisors Llc (Major Shareholder)
  2. Todd C Brady (CEO)
  3. Martin Joseph Joyce (Director)
  4. Life Sciences Maste Perceptive (President)
Learn More about top insider investors at Aldeyra Therapeutics.

Who are the major institutional investors of Aldeyra Therapeutics?

Aldeyra Therapeutics' top institutional shareholders include:
  1. Eagle Asset Management Inc. — 3.03%
  2. Verition Fund Management LLC — 2.66%
  3. Dimensional Fund Advisors LP — 1.52%
  4. Millennium Management LLC — 1.45%
  5. Geode Capital Management LLC — 0.80%
  6. Two Sigma Investments LP — 0.77%
Learn More about top institutional investors of Aldeyra Therapeutics stock.

Which major investors are selling Aldeyra Therapeutics stock?

In the last quarter, ALDX stock was sold by these institutional investors:
  1. Verition Fund Management LLC
  2. 683 Capital Management LLC
  3. Tang Capital Management LLC
  4. Renaissance Technologies LLC
  5. Two Sigma Investments LP
  6. Connor Clark & Lunn Investment Management Ltd.
  7. Susquehanna International Group LLP
  8. Parallax Volatility Advisers L.P.

Which major investors are buying Aldeyra Therapeutics stock?

Within the previous quarter, ALDX stock was acquired by institutional investors including:
  1. Eagle Asset Management Inc.
  2. Dimensional Fund Advisors LP
  3. Millennium Management LLC
  4. Marshall Wace LLP
  5. Victory Capital Management Inc.
  6. Victory Capital Management Inc.
  7. Thrivent Financial for Lutherans
  8. Group One Trading L.P.
During the last year, these company insiders have bought Aldeyra Therapeutics stock:
  1. Perceptive Advisors Llc (Major Shareholder)
  2. Todd C Brady (CEO)
  3. Martin Joseph Joyce (Director)
Learn More investors buying Aldeyra Therapeutics stock.
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel